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Abstract
Background—Heart failure with preserved ejection fraction (HFPEF) is common and 
characterized by exercise intolerance and lack of proven effective therapies. Exercise training has 
been shown to be effective in improving cardiorespiratory fitness (CRF) in patients with systolic 
heart failure. In this meta-analysis, we aim to evaluate the effects of exercise training on CRF, 
quality of life and diastolic function in patients with HFPEF.
Methods and Results—Randomized controlled clinical trials that evaluated the efficacy of 
exercise training in patients with HFPEF were included in this meta-analysis. Primary outcome of 
the study was change in CRF (measured as change in peak oxygen uptake). Impact of exercise 
training on quality of life (estimated using Minnesota living with heart failure score), left 
ventricular systolic and diastolic function was also assessed. The study included 276 patients that 
were enrolled in 6 randomized controlled trials. In the pooled data analysis, HFPEF patients 
undergoing exercise training had significantly improved CRF (L/min) (Mean difference: 2.72; 
95% CI: 1.79 to 3.65) and quality of life (Mean difference: −3.97; 95% CI: −7.21 to −0.72) as 
compared with the control group. However, no significant change was observed in the systolic 
function [Ejection Fraction – Weighted Mean difference (WMD): 1.26; 95% CI: −0.13% to 
2.66%] or diastolic function [E/A - WMD: 0.08; 95% CI:−0.01 to 0.16] with exercise training in 
HFPEF patients.
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Conclusions—Exercise training in patients with HFPEF is associated with an improvement in 
CRF and quality of life without significant changes in left ventricular systolic or diastolic function.
Keywords
heart failure with preserved ejection fraction; exercise training; meta-analysis
Heart failure with preserved ejection fraction (HFPEF) is common, representing 
approximately 50% of heart failure admissions.1, 2 Exercise intolerance is the primary 
symptom among patients with HFPEF. 3 While pharmacological therapies such as ACE 
inhibitors and mineralocorticoid receptor antagonists have failed to a mortality benefit in 
HFPEF, 2, 4-6 there are a number of studies showing significant improvement in exercise 
capacity in response to these agents. 7, 8 Left ventricular diastolic dysfunction has been 
identified as one of the mechanisms underlying exercise intolerance in these patients.9 As a 
result, there has been a significant interest in novel therapeutic approaches that could 
improve diastolic function and ameliorate exercise intolerance in HFPEF.
Exercise training is one such therapeutic approach that is associated with significant 
improvement in cardiorespiratory fitness in patients with HFREF.10, 11 While some studies 
have attributed this to exercise induced favorable changes in LV function and cardiac 
output, 11, 12 others have identified peripheral adaptations in the arterial and skeletal muscle 
function as the primary contributor to improvement in fitness after exercise training.13, 14 
Exercise training is also associated with improved exercise tolerance among sedentary, 
obese, and hypertensive subjects who are at high risk for HFPEF.15 Several recent studies 
have evaluated exercise training as a therapeutic management strategy in patients with 
HFPEF.16-21 While these studies were not designed to address clinical endpoints such as 
heart failure hospitalizations and mortality, they have demonstrated a variable degree of 
improvement in exercise tolerance and diastolic function in response to training. The aim of 
this meta-analysis is to assess the effects of exercise training on exercise tolerance, quality 
of life and diastolic function in patients with HFPEF.
Methods
Data sources and searches
A comprehensive computerized literature search of Medline, EMBASE, OVID, Web of 
Science, and Cochrane databases was conducted using MeSH terms and keywords including 
heart failure, diastolic heart failure, heart failure with normal ejection fraction, heart failure 
with preserved ejection fraction, exercise training, and cardiac rehabilitation. In addition, the 
institutional records were manually searched for available theses using the expertise of a 
medical librarian.
Study selection
We initially evaluated all comparative studies including randomized or non-randomized 
parallel group trials, pre-post within group design that enrolled adult patients (age ≥ 18 
years) with diastolic heart failure of any etiology (Figure 1, Supplemental Table 1). 
However, only randomized controlled trials (RCT) were included in the final analysis to 
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maintain consistency and obtain robust pooled estimates. Primary outcome of the study was 
change in cardiorespiratory fitness (measured as change in peak oxygen uptake in ml/kg/
min). Secondary outcomes that were also assessed in the study included change in 
Minnesota living with heart failure (MLWHF) score, markers of diastolic function (changes 
in E/A ratio and early deceleration time), and left ventricular ejection fraction. Studies 
failing to report at least one of the above pre-defined study outcomes were excluded from 
our analysis.
Data extraction
Full text articles were retrieved for all title-abstracts that met the inclusion criteria. Data 
extraction was then independently performed by the co-primary authors (AP and AP) using 
a standardized questionnaire. All discrepancies concerning study inclusion or outcomes were 
resolved by the senior author (JB). In cases of multiple publications arising from a single 
trial, only the updated trial with the maximum number of patients was included.
Data synthesis and statistical analysis
Meta-analysis of the outcomes was conducted using “Metan” and “Metareg” functions 
available for Stata™ version 12.1 statistical software (Stata Corporation, College Station, 
TX).22 The meta-analysis has been reported in accordance with the Preferred Reporting 
Items for Systematic reviews and Meta Analyses (PRISMA) guidelines. 23 We primarily 
used fixed effects modeling to conduct the meta-analysis of outcomes from included studies. 
We assessed for heterogeneity using the I2 test (I2 ≥ 25% was assumed to be a result of 
significant heterogeneity). In cases of significant heterogeneity, we reported a pooled 
estimate based on the random effects model. Weighted mean differences (WMD) and 
corresponding 95% confidence intervals were computed for all continuous outcomes. To 
assess the effect of demographic factors such as age and gender on treatment outcomes, 
random-effect meta-regression models were constructed for the primary outcome (change in 
cardiorespiratory fitness). Furthermore, to account for differences in the baseline measures 
of cardiorespiratory fitness and MLWHF score between control and training groups, we 
conducted additional meta-regression analysis for these outcomes (change in 
cardiorespiratory fitness and change in MLWHF score) adjusting for their baseline values. 
The variables included in the meta-regression model were identified a priori to safeguard 
against false-positive results because of an over-fitted model. Risk of bias analysis was 
performed using Cochrane collaboration’s assessment tool in RevMan version 5.2 
software24. Publication bias was assessed using the funnel plots and quantified by Egger’s 
regression test. All p-values were two-tailed with statistical significance specified at 0.05 
and confidence intervals (CI) reported at the 95% level.
Results
We included a total of 276 participants enrolled in 6 randomized controlled trials, with a 
mean follow-up duration of 12–24 weeks (weighted mean duration = 19 weeks). The 
baseline demographic and clinical characteristics of the study participants are summarized in 
Table 1. All 6 trials included well compensated HFPEF patients (ejection fraction ≥45%), 
stabilized on cardiac medications with no recent hospitalizations. The HFPEF definition and 
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exclusion criteria used in the included studies has been discussed in Table 2. The exercise 
training protocol, control group care and outcomes measured in the included trials has been 
discussed in Table 3. The study participants had an echocardiographic as well as 
cardiorespiratory fitness assessment at baseline and follow up.
Quality Assessment
The Cochrane risk of bias assessment tool was used to perform quality assessment 
(Supplemental Figure 1). During quality assessment, random sequence generation was 
observed in all studies. Blinded assessment of outcomes was performed in 5 of the 6 
included trials. Incomplete outcome data or selective reporting of results was not observed 
in any of the selected studies. We also didn’t observe any significant publication bias in the 
formal analysis.
Effect of Exercise training on cardiorespiratory fitness
Four studies reported exercise capacity at baseline and after exercise training, using 
symptom-limited cardiopulmonary exercise testing on a bicycle ergometer or treadmill. A 
greater improvement in peak oxygen uptake was observed among HFPEF patients 
undergoing exercise training vs. usual care patients in all the included trials (Supplemental 
Table 2). There was no significant statistical heterogeneity across studies reporting peak 
oxygen uptake. Pooling across the 4 trials using fixed effects meta-analysis showed that 
exercise training is associated with a significant improvement in peak oxygen uptake (ml/kg/
min) from baseline to follow-up among HFPEF patients (WMD: 2.72; 95% CI: 1.79 to 3.65; 
P-value = 0.0001; see Fig 2). Meta-regression analysis showed no significant effect of age, 
gender and baseline measure of peak oxygen uptake on the pooled WMD (Age: meta-
regression coefficient = −0.23; P-value: 0.42, Gender: meta-regression coefficient = −0.04; p 
value: 0.48, Baseline line measure of peak oxygen uptake: meta-regression coefficient = 
0.48; p value: 0.3)
Effect of exercise training on quality of life
All five studies reported an impact of exercise training on quality of life (determined using 
the MLWHF questionnaire). Clinically meaningful improvement in MLWHF total score 
(greater than 5 points reduction in MLWHF score from baseline to follow up) was observed 
among HFPEF patients undergoing exercise training in all the included trials (Supplemental 
Table 2). No significant heterogeneity was observed across the 5 trials. Pooling across the 5 
studies using fixed effect meta-analysis showed a statistically significant improvement in the 
quality of life score from baseline to follow up as assessed by the MLWHF questionnaire 
among exercise training participants as compared to the usual care group (WMD: −3.97; 
95% CI: −7.21 to −0.72; P-value = 0.02; see Fig 2). Meta-regression analysis showed no 
significant effect of baseline MLWHF score on the pooled WMD (meta-regression 
coefficient = −1.05; p value: 0.2)
Effect of exercise training on diastolic and systolic function
Five studies reported the impact of exercise training on diastolic function. E/A and 
deceleration time were reported as measures of diastolic function reported in 3 studies, 
Pandey et al. Page 4













whereas one study reported only E/A and another reported only E/e’ (Supplemental Table 
3). Pooling across all the available studies using fixed effect meta-analysis showed no 
significant change in E/A (WMD: 0.08; 95% CI: −0.01 to 0.16; P-value = 0.08; see Fig 3) or 
early deceleration time (ms) (WMD: 2.92; 95% CI: −18.56 to 24.41; P-value = 0.79; see Fig 
3) with exercise training as compared with the control group subjects. Similarly, we did not 
observe any significant change in systolic function (ejection fraction) with exercise training 
on fixed effect meta-analysis of pooled data from the 5 studies (WMD: 1.26%; 95% CI: 
−0.13% to 2.66%; P-value = 0.08; see Fig 3, Supplemental Table 3).
Safety of Exercise Training
No major adverse effects of exercise training were reported in the included studies (Table 4).
Discussion
In the present meta-analysis, we observe two important findings. First, exercise training 
improves cardiorespiratory fitness and quality of life in patients with HFPEF. Second, 
exercise training in these patients is not associated with any significant change in resting 
diastolic or systolic function. Taken together, these findings suggest that exercise training 
may improve cardiorespiratory fitness in patients with HFPEF through mechanisms 
independent of left ventricular function.
Exercise training has been shown to improve fitness and quality of life in asymptomatic 
hypertensive subjects who are at risk for HFPEF. 15, 25 Similarly, in patients with heart 
failure with reduced ejection fraction, studies have shown a consistent improvement in 
fitness and quality of life after exercise training. 10, 26 In the present study, we have 
extended these findings showing a favorable effect of exercise training on fitness and quality 
of life among patients with HFPEF.
The mechanism by which exercise training improved exercise tolerance in HFPEF is not 
completely clear. Exercise training has been shown to improve systolic and diastolic 
function in patients with HFREF.11, 27 However, in the present study, there was no 
significant change in diastolic function with exercise training in patients with HFPEF. It is 
important to note that for our meta-analysis, we used E/A and early deceleration time as 
measures of diastolic function because they were most commonly reported. E/E', a more 
specific measure of diastolic function, 28 was only reported in one included study by 
Edelmann et al, 18 and was not used for pooled analysis. Interestingly, Edelman et al did 
show a significant improvement in E/E' with exercise training.
Increased arterial stiffness and endothelial dysfunction have also been shown to contribute 
to exercise intolerance in patients with HFPEF. 21, 29-31 However, in a recent study by 
Kitzman et al,21 exercise training failed to improve the endothelial function and arterial 
stiffness in such patients. Another potential mechanism by which exercise training has been 
shown to improve cardiorespiratory fitness in asymptomatic, sedentary subjects is through 
physiological remodeling and associated improvement in stroke volume and cardiac output. 
However, recent works by Fujimoto et al 32 and Haykowsky et al 33 have shown that 
exercise training in HFPEF subjects is not associated with any significant change in cardiac 
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output. The impact of exercise training on arterial stiffness, endothelial function and cardiac 
output could not be assessed in the present meta-analysis because these outcomes were not 
reported in the majority of the clinical trials. Taken together, the available literature suggests 
that exercise training may improve exercise tolerance through peripheral mechanisms 
leading to an improved oxygen extraction in the active skeletal muscles.21, 33, 34 If so, this 
would mirror to some extent the results of studies investigating the mechanisms of 
improvement in exercise capacity following exercise training in patients with 
HFREF. 14, 35-37
Exercise intolerance is the primary symptom of HFPEF and an important determinant of 
quality of life. 3, 38 While pharmacological interventions have been ineffective in reducing 
HFPEF patient mortality, a substantial improvement in exercise capacity without a 
significant change in diastolic function was reported in a recent meta-analysis of all HFPEF 
drug trials. 8 Similar results were observed in the present meta-analysis using exercise 
training in these subjects. These findings suggest that exercise training can be utilized as an 
alternative therapeutic strategy for the improvement of symptoms in patients with HFPEF.
Findings in our study are similar to those in the meta-analysis of Taylor et al 39 who 
evaluated the impact of exercise training on HFPEF. However, more recent randomized 
control trials have been published since the latter study was completed in November 
2011.19-21 The present work, with twice as many study subjects, represents an updated and 
more comprehensive evaluation of the impact of exercise training in patients with HFPEF. 
Moreover, the previous meta-analysis included both randomized and non-randomized 
clinical trials that may have lead to potential bias because it was impossible to completely 
remove interference of unknown confounding factors.
There are several limitations in this study. First, we only have 6 clinical trials included in the 
meta-analysis reflecting the scarcity of randomized control trials in literature addressing this 
issue. This could be due to several challenges that are associated with exercise training trials 
among HFPEF patients. These include non-adherence and high drop out rates among 
training participants, time and resource intense nature of intervention, and difficulties with 
selection of right patient population that will benefit from exercise training. Furthermore, the 
sample size of some included trials was small resulting in wide confidence intervals for 
point estimates associated with study outcomes. This highlights the significance of pooled 
analysis that has been conducted in the present study. Second, the standard measure of 
diastolic function E/E' was not consistently reported in all the included clinical trials and 
was therefore not used for pooled analysis. Third, echocardiographic parameters are reported 
in only 4 of the 6 included studies and the meta-analysis may not be adequately powered to 
draw definitive conclusions about the impact of exercise training on echocardiographic 
parameters. Future studies with larger sample size are needed to determine the impact of 
exercise training on echocardiographic outcomes. Fourth, the mean follow-up duration in 
these clinical trials was relatively short (12–24 weeks) and longer duration follow-up may be 
needed to observe significant changes in left ventricular remodeling and diastolic function. 
Fifth, none of the included trials reported clinical outcomes such as heart failure, 
hospitalization, or mortality; therefore, we were unable to assess these points. Furthermore, 
it is difficult to evaluate the sustainability of effects of exercise training intervention on CRF 
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among HFPEF patients in the present meta-analysis since all the trials measured outcomes at 
the end of follow up. Finally, as with all meta-analyses, selection bias cannot be completely 
ruled out because articles were only retrieved from published trials.
Taken together, the findings from our study suggest that exercise training in patients with 
HFPEF improves cardiorespiratory fitness and quality of life without a significant change in 
LV diastolic function. Future studies among HFPEF patients with well characterized 
phenotype that have longer follow up duration, use more efficient and less resource intense 
exercise training protocols, and assess relevant clinical end-points are needed to determine if 
exercise training can be used as an effective management strategy for these patients in the 
real world.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Patients with HFPEF are older and most commonly present with symptoms of exercise 
intolerance. While exercise training is well accepted as a management strategy for heart 
failure with reduced ejection fraction, its role in management of HFPEF patients is not 
well established. In the present meta-analysis we observed that exercise training is 
associated with significant improvements in cardiorespiratory fitness and quality of life 
among HFPEF patients. These findings suggest that exercise training could be used as an 
alternative therapeutic strategy for management of HFPEF patients. This study also 
provides some insight into the potential mechanisms through which training may 
improve fitness among these patients. We did not observe any significant changes in left 
ventricular diastolic function with exercise training suggesting that other mechanisms 
may play an important role in exercise training associated improvement of fitness among 
these patients. Future studies that use more efficient, less resource intense training 
protocol and assess relevant clinical end-points such as HF hospitalization and mortality 
are needed to determine if exercise training can be established as an effective 
management strategy for HFPEF in the real world.
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Flow diagram for inclusion of studies in the Meta-analysis
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Forest Plot showing effect of exercise training on cardiorespiratory fitness, measured as 
peak oxygen uptake (ml/kg/min) and quality of life, estimated using Minnesota living with 
heart failure (MLWHF) score, among participants with heart failure and preserved ejection 
fraction. WMD indicated weighted mean difference.
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Forest plot showing effect of exercise training on left ventricular diastolic function (E/A 
ratio and early deceleration time) and left ventricular ejection fraction (LVEF) among 
participants with heart failure and preserved ejection fraction. WMD indicated weighted 
mean difference.
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Table 1















16/16 27/26 20/44 13/12 11/20 31/32
Women (%) 100 75 36 48 29 76
Caucasian (%) 59 70 NA NA NA 68
Mean age, years 68 ± 11 69.5 ± 5.5 65 ± 7 64.4 ± 6.4 62.9 ±10.2 70 ± 7
Mean Body mass
index, Kg/m2
33.5 ± 6.5 0.5 ± 6.5 31 ± 5 32.1 ± 6.4 28.4 ± 4.5 32.1 ± 6.6
NYHA Class II (%)













Hypertension (%) 88 68 86 16 68 89
Diabetes (%) 31 17 14 16 35 24
Baseline Systolic BP,
mm Hg
NA 147± 20 140 ± 19 131±11 NA 146 ± 17
Baseline Heart Rate,
beats/min
NA 69 ± 13 66 ± 11 NA NA NA















6 min walk at
baseline, feet
832 ± 366 1452 ± 332 1794 ± 282 NA NA 1450 ± 300
Peak oxygen uptake
baseline, ml/kg/min
NA 13.3 ± 2.6 16.3 ± 4.8 13.2 ± 3.9 13.6 ± 4.9 14.1± 3.0
Blinded assessment
of outcomes
No Yes Yes Yes Yes Yes
NYHA: New York Heart Association; BP: Blood Pressure; EF: Ejection Fraction; Data represented as mean ± SD
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Table 2
Heart Failure with Preserved Ejection Fraction definition and exclusion criteria use in the studies included in 
the meta-analysis
Trial Criteria used for Defining HFPEF Exclusion Criteria
Gary et al 200416 • NYHA Class II or III Diastolic Heart Failure on chart review.
• Ejection Fraction > 50%
• Stabilized on cardiac medications for at least 3 months








• Symptoms and signs defined by NHANES HF score >3
• History of acute pulmonary edema
OR
At least 2 of the following symptoms: dyspnea on exertion, 
paroxysmal nocturnal dyspnea, orthopnea, lower-extremity edema, or 
exertional fatigue.
• Well compensated, stabilized on cardiac medications for at-least 6 
weeks
Significant coronary artery disease,




• Symptomatic (NYHA II/III) with ejection fraction > 50%
• Echo determined diastolic dysfunction in sinus rhythm,
• At least 1 cardiovascular risk factor
• Stabilized on cardiac medications for at least 4 weeks
Significant coronary artery disease,
valvular heart disease or pulmonary
disease, anemia, uncontrolled
Hypertension, arrhythmia
Smart et al 201220 • Significant Dyspnea on exertion with Delayed relaxation or 
Pseudonormal filling on echo.
Hx of coronary artery disease
COPD, Valvular disease




changes during treadmill test
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Table 3








• Self-monitored community based 
walking intervention + home education 
program.
• Walking intervention with ambulatory 
Heart rate monitoring, initially at an 
intensity of 40% of target heart rate for 













• Supervised endurance training (track 
walking + cycling) 3 times per week
• Week 1-2: exercise at 40-50% of peak 
VO2 with gradually increasing duration
• Week 3-16: exercise exercise intensity 
at 60-70% of peak VO2 and duration 
increased to 15-20 min.
Telephone call 
follow-
up every 2 weeks
without addressing
exercise behavior
16 weeks 1. Peak Oxygen uptake.
2. Systolic, diastolic function by 
Echo
3. LV dimensions
4. Quality of life
Edelmann
et al 201118
• Supervised, endurance (cycling) + 
resistance training
• Week 1-4: aerobic endurance training at 
50-60% of baseline peak VO2
• Week 5-12: aerobic endurance at 70% 





24 weeks 1. Peak Oxygen uptake.
2. Systolic, diastolic function by 
Echo
3. LV dimensions
4. Quality of life
Alves
et al 201219
• Supervised endurance training on 
treadmill/cycle ergometer.
• Week 1-4: training at 70-75% of peak 
VO2.





24 weeks 1. Peak Oxygen uptake.
2. Systolic, diastolic function by 
Echo
3. LV dimensions
4. Quality of life
Smart
et al 201220
• Supervised, outpatient, cycle ergometer 
exercise training.
• Initial intensity of 60-70% peak VO2.





16 weeks 1. Peak Oxygen uptake.
2. Systolic, diastolic function by 
Echo
3. LV dimensions
4. Quality of life
Peak VO2: Peak Oxygen Uptake; LV: left ventricle
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Table 4
Exercise associated adverse events as reported in the studies included in the meta-analysis
Studies Exercise associated Adverse Events
Gary et al 200416 No adverse events
Kitzman et al 201017 No adverse events
Edelmann et al
201118
No serious adverse events.
Palpitations (n = 2); dyspnea (n = 2);
Muscle discomfort (n = 9)
Kitzman et al 201321 1 exercise patient with transient
hypoglycemia
Smart et al 201220 Not reported
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